tm logo
ALENTIS
Live/Registered
REGISTERED

on 02 Apr 2024

Last Applicant/ Owned by

CH-4123 Allschwil

CH

Serial Number

79338873 filed on 07th Feb 2022

Registration Number

7341501 registered on 02th Apr 2024

in the Principal Register

Correspondent Address

Dermot J. Horgan

Dermot J. Horgan IpHorgan Ltd.

Suite 125

Buffalo Grove, IL 60089

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ALENTIS

Scientific and medical research and development in the field of fibrosis, autoimmune diseases, and cancer; biotechnological research services in the field of fibrosis, autoimmune diseases, and cancer; providing scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancerous diseases; scientific advice relating to medici Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical analysis services for diagnosing cancer; RNA or DNA analysis for cancer diagnosis and prognosis; provision of medical information in the field of cancer prevention, screening, diagnosis and treatment; medical advice and information regarding pharmaceutical and medical products; medical testing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific and medical research and development in the field of fibrosis, autoimmune diseases, and cancer; biotechnological research services in the field of fibrosis, autoimmune diseases, and cancer; providing scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancerous diseases; scientific advice relating to medicine


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment; pharmaceutical preparations and substances for cancer treatment; pharmaceutical preparations and substances for cancer prevention


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79338873

Mark Type

No Service Mark

Attorney Docket Number

No WWL 0001 US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Oct 2024FINAL DISPOSITION NOTICE SENT TO IB
16th Oct 2024FINAL DISPOSITION PROCESSED
03rd Jul 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02th Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
02th Apr 2024REGISTERED-PRINCIPAL REGISTER
16th Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Jan 2024PUBLISHED FOR OPPOSITION
13th Jan 2024NOTIFICATION PROCESSED BY IB
27th Dec 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27th Dec 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED